vorinostat has been researched along with Schistosoma mansoni Infection in 2 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heimburg, T | 1 |
| Chakrabarti, A | 1 |
| Lancelot, J | 2 |
| Marek, M | 2 |
| Melesina, J | 2 |
| Hauser, AT | 2 |
| Shaik, TB | 1 |
| Duclaud, S | 1 |
| Robaa, D | 1 |
| Erdmann, F | 1 |
| Schmidt, M | 1 |
| Romier, C | 2 |
| Pierce, RJ | 2 |
| Jung, M | 2 |
| Sippl, W | 2 |
| Stolfa, DA | 1 |
| Walter, A | 1 |
| Leproult, E | 1 |
| Rumpf, T | 1 |
| Wurtz, JM | 1 |
| Cavarelli, J | 1 |
2 other studies available for vorinostat and Schistosoma mansoni Infection
| Article | Year |
|---|---|
Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis.
Topics: Animals; Dose-Response Relationship, Drug; Drug Delivery Systems; Helminth Proteins; Histone Deacety | 2016 |
Molecular basis for the antiparasitic activity of a mercaptoacetamide derivative that inhibits histone deacetylase 8 (HDAC8) from the human pathogen schistosoma mansoni.
Topics: Animals; Antiparasitic Agents; Apoptosis; Biocatalysis; Crystallography, X-Ray; Helminth Proteins; H | 2014 |